Amsacrine is an acridine-based antineoplastic agent used mainly for acute leukemias, working by intercalating into DNA and inhibiting topoisomerase II, which causes DNA strand breaks and triggers apoptosis in rapidly dividing cancer cells; it was developed in the 1970s as a modified DNA-intercalating compound to enhance antitumor activity while reducing toxicity, and clinical studies in Europe and North America established its effectiveness, leading to its use alone or in combination with other chemotherapeutics in leukemia treatment protocols.
Image
